Phi Therapeutics, Inc. is doing business as Phyla. At Phyla, we use cutting edge microbiome research and bacteriophage technology to develop new approaches to acne and other chronic diseases, providing long-term solutions without side effects. We leverage the microbiome and tackle the root cause, bacterial overgrowth, without causing collateral damage. Our products are clinically proven to kill only the bad bacteria, improve acne, and recalibrate the microbiome for long-term skin health. Additionally, our bacteriophage platform presents capabilities that can tackle many other bacterial diseases.